幹細胞バンクの世界市場2018-2022:成体幹細胞、臍帯血幹細胞、胚性幹細胞

【英語タイトル】Global Stem Cell Banking Market 2018-2022

Technavioが出版した調査資料(IRTNTR20140)・商品コード:IRTNTR20140
・発行会社(調査会社):Technavio
・発行日:2018年1月2日
・ページ数:113
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥392,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥560,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Technavio社が発行した当調査レポートでは、幹細胞バンクの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、幹細胞バンクの世界市場規模及び予測、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。Technavio社は幹細胞バンクの世界市場が2018-2022年期間中に年平均12.76%成長すると予測しています。当レポート上に記載されている主な企業は、AMAG Pharmaceuticals、Cordlife、Cryo-Cell International、Esperite等です。
【レポートの概要】

About Stem Cell Banking
The global stem cell banking market is a closely related market to the global regenerative medicine market. Regenerative medicine is a key branch of modern medicine, which has emerged as a combination of tissue engineering and molecular biology. Regenerative medicine aims to re-engineer human cells, tissues, or organs, which can replace or restore the normal functioning of impaired cells, tissues; or organs.

Technavio’s analysts forecast the global stem cell banking market to grow at a CAGR of 12.76% during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global stem cell banking market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Stem Cell Banking Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• AMAG Pharmaceuticals
• Cordlife
• Cryo-Cell International
• Esperite

[Other prominent vendors]
• Cellular Dynamics International
• China Cord Blood Corporation
• Cordvida
• Cryo Stemcell
• Cryoviva India
• Cytori Therapeutics
• Lifecell
• PerkinElmer
• Reelabs
• Smart Cells International
• Stemade Biotech
• StemCyte

[Market driver]
• Growing prevalence of cancer
• For a full, detailed list, view our report

[Market trend]
• Growing acceptance of stem cell therapies
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY CELL TYPE
• Overview
• Comparison by cell type
• Adult stem cells
• Umbilical cord blood stem cells
• Embryonic stem cells
• Market opportunity by cell type

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Stem cell banking market in Americas
• Stem cell banking market in EMEA
• Stem cell banking market in APAC
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 12: MARKET TRENDS
• Increasing implementation of inorganic growth strategies
• Rising demand for personalized medicines
• Growing acceptance of stem cell therapies

PART 13: VENDOR LANDSCAPE
• Competitive scenario

PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• AMAG Pharmaceuticals
• Cordlife
• Cryo-Cell International
• Esperite
• Other prominent vendors

PART 15: APPENDIX
• List of abbreviations

[List of Exhibits] Exhibit 01: Global stem cell banking market: Related market
Exhibit 02: Global stem cell banking market: Market characteristics
Exhibit 03: Global stem cell banking market: Market segments
Exhibit 04: Market definition: Inclusions and exclusions checklist
Exhibit 05: Global stem cell banking market: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global stem cell banking market: Market size and forecast 2017-2022 ($ billions)
Exhibit 08: Global stem cell banking market: Year-over-year growth 2017-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of suppliers
Exhibit 12: Threat of new entrants
Exhibit 13: Threat of substitutes
Exhibit 14: Threat of rivalry
Exhibit 15: Market condition: Five forces 2017
Exhibit 16: Market condition: Five forces 2022
Exhibit 17: Global stem cell banking market: Segmentation by cell type 2017-2022 (% share)
Exhibit 18: Global stem cell banking market: Comparison by cell type
Exhibit 19: Global adult stem cell banking market 2017-2022 ($ billions)
Exhibit 20: Global adult stem cell banking market: Year-over-year growth 2018-2022 (%)
Exhibit 21: Global umbilical cord blood stem cell banking market 2017-2022 ($ billions)
Exhibit 22: Global umbilical cord blood stem cell banking market: Year-over-year growth 2018-2022 (%)
Exhibit 23: Global embryonic stem cell banking market 2017-2022 ($ billions)
Exhibit 24: Global embryonic stem cell banking market: Year-over-year growth 2018-2022 (%)
Exhibit 25: Global stem cell banking market: Market opportunity by cell type
Exhibit 26: Global stem cell banking market: Customer landscape
Exhibit 27: Global stem cell banking market: Segmentation by geography 2017-2022 (% share)
Exhibit 28: Regional comparison
Exhibit 29: Stem cell banking market in Americas 2017-2022 ($ billions)
Exhibit 30: Stem cell banking market in Americas: Year-over-year growth 2018-2022 (%)
Exhibit 31: Top three countries in Americas
Exhibit 32: Stem cell banking market in EMEA 2017-2022 ($ billions)
Exhibit 33: Stem cell banking market in EMEA: Year-over-year growth 2018-2022 (%)
Exhibit 34: Top three countries in EMEA
Exhibit 35: Stem cell banking market in APAC 2017-2022 ($ billions)
Exhibit 36: Stem cell banking market in APAC: Year-over-year growth 2018-2022 (%)
Exhibit 37: Top three countries in APAC
Exhibit 38: Cancer severity across EU in 2013 and cancer incidence in US in 2014
Exhibit 39: Year-over-Year growth and growth rate of stem cell research spending in US 2013-2016 ($ billions)
Exhibit 40: CIRM funding in stem cell research 2014 ($ billions)
Exhibit 41: CIRM active programs 2014
Exhibit 42: EC funding for regenerative medicine
Exhibit 43: Strategic success factors of vendors in market
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: AMAG Pharmaceuticals: Overview
Exhibit 47: AMAG Pharmaceuticals: Business segments
Exhibit 48: AMAG Pharmaceuticals: Organizational developments
Exhibit 49: AMAG Pharmaceuticals: Geographic focus
Exhibit 50: AMAG Pharmaceuticals: Segment focus
Exhibit 51: AMAG Pharmaceuticals: Key offerings
Exhibit 52: Cordlife: Overview
Exhibit 53: Cordlife: Business segments
Exhibit 54: Cordlife: Organizational developments
Exhibit 55: Cordlife: Geographic focus
Exhibit 56: Cordlife: Segment focus
Exhibit 57: Cordlife: Key offerings
Exhibit 58: Cryo-Cell International: Overview
Exhibit 59: Cryo-Cell International: Business segments
Exhibit 60: Cryo-Cell International: Organizational developments
Exhibit 61: Cryo-Cell International: Geographic focus
Exhibit 62: Cryo-Cell International: Segment focus
Exhibit 63: Cryo-Cell International: Key offerings
Exhibit 64: Esperite: Overview
Exhibit 65: Esperite: Business segments
Exhibit 66: Esperite: Organizational developments
Exhibit 67: Esperite: Geographic focus
Exhibit 68: Esperite: Segment focus
Exhibit 69: Esperite: Key offerings



【掲載企業】

AMAG Pharmaceuticals, Cordlife, Cryo-Cell International, Esperite, Cellular Dynamics International, China Cord Blood Corporation, Cordvida, Cryo Stemcell, Cryoviva India, Cytori Therapeutics, Lifecell, PerkinElmer, Reelabs, Smart Cells International, Stemade Biotech, and StemCyte.


★調査レポート[幹細胞バンクの世界市場2018-2022:成体幹細胞、臍帯血幹細胞、胚性幹細胞] (コード:IRTNTR20140)販売に関する免責事項を必ずご確認ください。
★調査レポート[幹細胞バンクの世界市場2018-2022:成体幹細胞、臍帯血幹細胞、胚性幹細胞]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆